Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
RIZATRIPTAN SANIS HEALTH INC Actual shortage 10MG Updated Report 2024-11-14 240737
OXY.IR PURDUE PHARMA Actual shortage 5MG Updated Report 2024-11-14 242888
LIPIODOL ULTRA FLUID GUERBET Resolved 380MG Updated Report 2024-11-14 237698
DESVENLAFAXINE SANIS HEALTH INC Resolved 50MG Updated Report 2024-11-14 231999
DESVENLAFAXINE SANIS HEALTH INC Resolved 100MG Updated Report 2024-11-14 231507
AURO-TENOFOVIR AURO PHARMA INC Resolved 300MG Updated Report 2024-11-14 217670
TEGRETOL CR NOVARTIS PHARMACEUTICALS CANADA INC Actual shortage 200MG Updated Report 2024-11-13 235978
VITAMIN B12 SANDOZ CANADA INCORPORATED Resolved 1000MCG Updated Report 2024-11-13 238955
CARBOLITH BAUSCH HEALTH, CANADA INC. Resolved 300MG Updated Report 2024-11-13 239782
WELLBUTRIN XL BAUSCH HEALTH, CANADA INC. Resolved 150MG Updated Report 2024-11-13 240257
MANERIX BAUSCH HEALTH, CANADA INC. Anticipated shortage 150MG Updated Report 2024-11-13 240916
CYANOCOBALAMIN INJECTION USP HIKMA CANADA LIMITED Anticipated shortage 1000MCG New Report 2024-11-13 242881
LEVOFLOXACIN IN 5% DEXTROSE INJECTION HIKMA CANADA LIMITED Actual shortage 5MG Updated Report 2024-11-13 242878
ENALAPRILAT INJECTION USP HIKMA CANADA LIMITED Actual shortage 1.25MG Updated Report 2024-11-13 231317
ROCURONIUM BROMIDE INJECTION HIKMA CANADA LIMITED Actual shortage 10MG Updated Report 2024-11-13 240847
CYANOKIT SERB S.A. Actual shortage 5G Updated Report 2024-11-13 242390
TRANDATE PALADIN PHARMA INC. Actual shortage 200MG New Report 2024-11-13 242865
TRANDATE PALADIN PHARMA INC. Actual shortage 100MG New Report 2024-11-13 242860
DIFLUCAN PFIZER CANADA ULC Anticipated shortage 2MG New Report 2024-11-13 242857
MANNITOL INJECTION USP ICU MEDICAL CANADA INC Anticipated shortage 20% Updated Report 2024-11-13 240224

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
INVOKAMET JANSSEN INC Discontinued 500MG 150MG Updated Report 2024-11-13 230850
PEDIACEL SANOFI PASTEUR LIMITED Discontinued 5MCG 20MCG 30MCG 10MCG 32UNIT 8UNIT 40UNIT 5LF 15LF 20MCG 3MCG Updated Report 2024-11-11 206912
AUBAGIO SANOFI-AVENTIS CANADA INC Discontinued 14MG Updated Report 2024-11-09 226847
GAVRETO HOFFMANN-LA ROCHE LIMITED To be discontinued 100MG New Report 2024-11-06 242142
AERMONY RESPICLICK TEVA CANADA LIMITED Discontinued 55MCG New Report 2024-11-05 242101